Chr-2797
* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS No. | 238750-77-1 | Cat. No. | BCP02167 |
Name | Chr-2797 | ||
Synonyms | Tosedostat;BB-76163;BB 76163;BB76163;Chr 2797;Chr2797; | ||
SMILES | |||
Chemical Name | |||
Formula | C21H30N2O6 | M. Wt | 406.47 |
Purity | 98% | Storage | Store at 4-8°C |
Description | CHR-2797 has almost no effect on Aminopeptidase B, PILSAP, LTA4 hydrolase and MetAP-2 activity with IC50 values of >1 uM, >5 uM, >10 uM and >30 uM, respectively. CHR-2797 is converted into a pharmacologically active acid product (CHR-79888) inside cells, which shows significant inhibitory activity towards LTA4 hydrolase with IC50 of 8 nM. CHR-2797 exhibits profound anti-proliferative effects against a range of cancer cell lines such as U-937, HL-60, KG-1 and GDM-1 with IC50 values of 10 nM, 30 nM, 15 nM and 15 nM, respectively, but is inactive against HuT 78 and Jurkat E6-1 with IC50 values of >10 uM. There is no obvious correlation between sensitivity to CHR-2797 and the mutational status of p53, PTEN, or K-Ras in cells. CHR-2797 shows selectivity for transformed cells (MrC5-SV2 or K-ras NRK) over non-transformed cells (MrC5 or NRK). CHR-2797 (6 μM) treatment leads to the up-regulation of genes involved in amino acid transport and metabolic pathways, the phosphorylation of eukaryotic |
Recommend Products
More >Tags:Chr-2797 supplier,Chr-2797 purchase,Chr-2797 manufacturer,Chr-2797 distributor,Chr-2797 cost,Chr-2797 buy,Chr-2797 for sale